Autopsy report · NCT03411837

Dupilumab Phase 4 Study

“Investigator moved from institution.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 10 months before it stopped.
• 46 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Northwestern University

Sponsor type

University, hospital or other

Conditions

Atopic Dermatitis

Interventions

Dupilumab

Participants

46

Sites

1

Countries

United States

Trials that died the same way

• Impact of Statins on Cytokine Expression in Pneumonia
  “Investigator left institution.” (89% match in meaning)
• Intralesional Tetracycline Injection in the Treatment of Chalazia
  “Investigator left the institution” (87% match in meaning)
• A Study of Oral L-citrulline in Sickle Cell Disease
  “Principal Investigator moved to another institution” (86% match in meaning)
• Individualized Repetitive Transcranial Magnetic Stimulation for Auditory Verbal Hallucinations
  “Investigator departed from institution” (85% match in meaning)
• Use of Cast Iron Pots to Improve Maternal Anemia
  “Original investigator has left the institution.” (85% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.